Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Corcept Therapeutics (NQ: CORT ) 43.93 +0.65 (+1.50%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Corcept Therapeutics < Previous 1 2 3 4 5 6 7 Next > Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer June 27, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Analyst Expectations for Corcept Therapeutics's Future May 26, 2023 Via Benzinga Corcept Therapeutics's Return On Capital Employed Overview May 10, 2023 Via Benzinga Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update May 03, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Analyst Ratings for Corcept Therapeutics April 04, 2023 Via Benzinga Analyst Expectations for Corcept Therapeutics's Future March 08, 2023 Via Benzinga Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call April 26, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023 April 11, 2023 Via Benzinga Corcept Therapeutics Announces Final Results of Tender Offer April 05, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Short Volatility Alert: Corcept Therapeutics April 05, 2023 On Tuesday, shares of Corcept Therapeutics (NASDAQ: CORT) experienced volatile short activity. After the activity, the stock price went up +1.66% to $22.02. The overall sentiment for CORT has been... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023 April 04, 2023 Via Benzinga Corcept Therapeutics Announces Preliminary Results of Tender Offer April 03, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Initiates CATALYST Clinical Trial March 28, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock March 06, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update February 28, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023 February 15, 2023 Via Benzinga Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call February 14, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation February 13, 2023 From Corcept Therapeutics Incorporated Via GlobeNewswire EQUITY ALERT: Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation – CORT December 28, 2022 From The Rosen Law Firm, P.A. Via Business Wire INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses to Contact the Firm December 16, 2022 From The Schall Law Firm Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses to Contact the Firm December 15, 2022 From The Schall Law Firm Via Business Wire 5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More December 15, 2022 The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies. Via Benzinga Our 7 Top Biotech Stock Picks for 2023 December 09, 2022 Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023. Via InvestorPlace Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals December 08, 2022 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Provides Miricorilant Clinical Development Update December 08, 2022 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update November 03, 2022 From Corcept Therapeutics Incorporated Via GlobeNewswire Corcept Therapeutics's Earnings: A Preview November 02, 2022 Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call October 27, 2022 From Corcept Therapeutics Incorporated Via GlobeNewswire These 3 Stocks Are Winning the Bear Market -- Here's How October 21, 2022 Picking the right markets to compete in makes surviving bear markets much more manageable for these companies. Via The Motley Fool 7 Under-the-Radar Stocks With 100% Upside Potential October 17, 2022 If you're looking for under-the-radar stocks in the current market environment, you're likely to find many imposters so tread carefully. Via InvestorPlace < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.